Speaker illustration

Assistant Professor Lazar Velicki

Institute of Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia)

In silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial cardiomyopathy – SILICOFCM.

Event: Digital Health 2019

Topic: Big Data and Digital Twin

Session: Data Analysis


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb